Management of Seroma After Posterior Lumbar Spine Decompression
Launched by KAFRELSHEIKH UNIVERSITY · Jul 2, 2025
Trial Information
Current as of July 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to best identify and manage a condition called seroma, which is a buildup of fluid that can happen after a type of back surgery known as posterior lumbar spine decompression. This surgery is done to relieve pressure on the nerves in the lower back. The study aims to understand how often seromas occur, what symptoms they cause, and the most effective ways to treat them.
People who are 18 years or older and scheduled to have this specific back surgery may be able to join the study. To participate, they should not have had previous surgery on their lower back, active infections, cancer, serious medical problems that affect healing or surgery safety, or be unable to have general anesthesia. Although the study is not yet recruiting participants, those who join can expect their care team to closely monitor them for signs of seroma and explore different treatment options if it develops. This research could help improve recovery and reduce complications for future patients having this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years.
- • Both sexes.
- • Patients undergoing elective posterior lumbar spine decompression.
- Exclusion Criteria:
- • History of previous lumbar spine surgery.
- • Active spinal infection, trauma, or malignancy.
- • Severe medical comorbidities that contraindicate surgery or influence wound healing (e.g., uncontrolled diabetes, immunosuppression, severe cardiovascular disease).
- • Patients unfit for general anesthesia.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, Kafr Elsheikh Governorate, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported